Clinical Data

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Lilly links amylin drug to 20% weight loss, races to phase 3

Eli Lilly saw 20.1% weight loss at Week 48, encouraging the drugmaker to prepare to enter phase 3 next month.
Nick Paul Taylor Nov 6, 2025 8:20am
theatre stage with red curtains

Novartis’ phase 3 wins in Sjögren's see high placebo effect

Oct 29, 2025 12:03pm
Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background

Kyverna links CAR-T to autoimmune improvements in small trial

Oct 29, 2025 10:00am
Sketch of lungs

Edesa claims survival win for phase 3 respiratory failure trial

Oct 28, 2025 9:45am
decision path change of plans arrows business decision

Aldeyra drops and swaps RASP assets in response to data

Oct 28, 2025 9:10am
hurdles

BridgeBio aces phase 3 rare disease test, clearing path to FDA

Oct 27, 2025 7:00am